129 related articles for article (PubMed ID: 22619123)
1. CD147 immunohistochemistry discriminates between reactive mesothelial cells and malignant mesothelioma.
Pinheiro C; Longatto-Filho A; Soares TR; Pereira H; Bedrossian C; Michael C; Schmitt FC; Baltazar F
Diagn Cytopathol; 2012 Jun; 40(6):478-83. PubMed ID: 22619123
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer.
Pinheiro C; Longatto-Filho A; Simões K; Jacob CE; Bresciani CJ; Zilberstein B; Cecconello I; Alves VA; Schmitt F; Baltazar F
Eur J Cancer; 2009 Sep; 45(13):2418-24. PubMed ID: 19628385
[TBL] [Abstract][Full Text] [Related]
3. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
Kim Y; Choi JW; Lee JH; Kim YS
Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
[TBL] [Abstract][Full Text] [Related]
4. Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma.
Pinheiro C; Albergaria A; Paredes J; Sousa B; Dufloth R; Vieira D; Schmitt F; Baltazar F
Histopathology; 2010 Jun; 56(7):860-7. PubMed ID: 20636790
[TBL] [Abstract][Full Text] [Related]
5. CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models.
Schneiderhan W; Scheler M; Holzmann KH; Marx M; Gschwend JE; Bucholz M; Gress TM; Seufferlein T; Adler G; Oswald F
Gut; 2009 Oct; 58(10):1391-8. PubMed ID: 19505879
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of lactate/proton symporters MCT1, MCT4, and their chaperone CD147 expressions in urothelial carcinoma of the bladder.
Choi JW; Kim Y; Lee JH; Kim YS
Urology; 2014 Jul; 84(1):245.e9-15. PubMed ID: 24857275
[TBL] [Abstract][Full Text] [Related]
7. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis.
Su J; Chen X; Kanekura T
Cancer Lett; 2009 Jan; 273(1):140-7. PubMed ID: 18778892
[TBL] [Abstract][Full Text] [Related]
8. Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis.
Martins SF; Amorim R; Viana-Pereira M; Pinheiro C; Costa RF; Silva P; Couto C; Alves S; Fernandes S; Vilaça S; Falcão J; Marques H; Pardal F; Rodrigues M; Preto A; Reis RM; Longatto-Filho A; Baltazar F
BMC Cancer; 2016 Jul; 16():535. PubMed ID: 27460659
[TBL] [Abstract][Full Text] [Related]
9. RNA interference targeting CD147 inhibits the proliferation, invasiveness, and metastatic activity of thyroid carcinoma cells by down-regulating glycolysis.
Huang P; Chang S; Jiang X; Su J; Dong C; Liu X; Yuan Z; Zhang Z; Liao H
Int J Clin Exp Pathol; 2015; 8(1):309-18. PubMed ID: 25755717
[TBL] [Abstract][Full Text] [Related]
10. Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration.
De Saedeleer CJ; Porporato PE; Copetti T; Pérez-Escuredo J; Payen VL; Brisson L; Feron O; Sonveaux P
Oncogene; 2014 Jul; 33(31):4060-8. PubMed ID: 24166504
[TBL] [Abstract][Full Text] [Related]
11. Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells.
Izumi H; Takahashi M; Uramoto H; Nakayama Y; Oyama T; Wang KY; Sasaguri Y; Nishizawa S; Kohno K
Cancer Sci; 2011 May; 102(5):1007-13. PubMed ID: 21306479
[TBL] [Abstract][Full Text] [Related]
12. Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231.
Gallagher SM; Castorino JJ; Wang D; Philp NJ
Cancer Res; 2007 May; 67(9):4182-9. PubMed ID: 17483329
[TBL] [Abstract][Full Text] [Related]
13. Genetic disruption of lactate/H+ symporters (MCTs) and their subunit CD147/BASIGIN sensitizes glycolytic tumor cells to phenformin.
Marchiq I; Le Floch R; Roux D; Simon MP; Pouyssegur J
Cancer Res; 2015 Jan; 75(1):171-80. PubMed ID: 25403912
[TBL] [Abstract][Full Text] [Related]
14. Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer.
Pértega-Gomes N; Vizcaíno JR; Miranda-Gonçalves V; Pinheiro C; Silva J; Pereira H; Monteiro P; Henrique RM; Reis RM; Lopes C; Baltazar F
BMC Cancer; 2011 Jul; 11():312. PubMed ID: 21787388
[TBL] [Abstract][Full Text] [Related]
15. Monocarboxylate transporters 1 and 4 are associated with CD147 in cervical carcinoma.
Pinheiro C; Longatto-Filho A; Pereira SM; Etlinger D; Moreira MA; Jubé LF; Queiroz GS; Schmitt F; Baltazar F
Dis Markers; 2009; 26(3):97-103. PubMed ID: 19597291
[TBL] [Abstract][Full Text] [Related]
16. MCT1, MCT4 and CD147 expression and 3-bromopyruvate toxicity in colorectal cancer cells are modulated by the extracellular conditions.
Pereira-Vieira J; Azevedo-Silva J; Preto A; Casal M; Queirós O
Biol Chem; 2019 May; 400(6):787-799. PubMed ID: 30699066
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of MCT1 and CD147 in equine skeletal muscle fibres.
Mykkänen AK; Hyyppä S; Pösö AR; Ronéus N; Essén-Gustavsson B
Res Vet Sci; 2010 Dec; 89(3):432-7. PubMed ID: 20435326
[TBL] [Abstract][Full Text] [Related]
18. MCT1 and its accessory protein CD147 are differentially regulated by TSH in rat thyroid cells.
Fanelli A; Grollman EF; Wang D; Philp NJ
Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1223-9. PubMed ID: 14607782
[TBL] [Abstract][Full Text] [Related]
19. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
20. Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets.
Miranda-Gonçalves V; Honavar M; Pinheiro C; Martinho O; Pires MM; Pinheiro C; Cordeiro M; Bebiano G; Costa P; Palmeirim I; Reis RM; Baltazar F
Neuro Oncol; 2013 Feb; 15(2):172-88. PubMed ID: 23258846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
